Regular blood transfusion therapy could significantly reduce the incidence of recurrent cerebral infarcts in children with sickle cell anemia, which occur in approximately one-third of children with the disease.
The Food and Drug Administration (FDA) has granted marketing approval of the KRONUS Zinc Transporter 8 Autoantibody (ZnT8Ab) ELISA Assay, the first ZnT8Ab test to help determine if a person has type 1 diabetes.
AliveCor announced that the Food and Drug Administration (FDA) has granted clearance for its algorithm to detect atrial fibrillation (AFib).
For healthy adults challenged with respiratory syncytial virus (RSV), an oral RSV-entry inhibitor, GS-5806, is associated with reduced viral load.
More than 40% of women undergo breast reconstruction following mastectomy and most patients are satisfied with the reconstruction decision-making process.
A defined process is necessary to help physicians hire the right staff for their practice, according to a new article.
GlaxoSmithKline announced that the Food and Drug Administration (FDA) has approved Arnuity Ellipta (fluticasone furoate inhalation powder) for the maintenance treatment of asthma as prophylactic therapy in patients ≥12 years old.
San Antonio, TX has developed a novel program to assist sending citizens with mental health issues to treatment, rather than jail.
Medications that are commonly linked to agranulocytosis development include clozapine, an atypical antipsychotic used in the treatment of schizophrenia, trimethoprim-sulfamethoxazole, an antibiotic, and methimazole, an agent for treating hyperthyroidism.
Tim Shaw, a 30-year-old retired NFL player announced this week that he is suffering from amyotrophic lateral sclerosis (ALS); his announcement adds to the growing concern regarding a potential link between professional football and ALS.